0.00Open13.10Pre Close0 Volume1 Open Interest90.00Strike Price0.00Turnover305.28%IV3.73%PremiumDec 27, 2024Expiry Date10.12Intrinsic Value100Multiplier0DDays to Expiry2.98Extrinsic Value100Contract SizeAmericanOptions Type-0.9683Delta0.0140Gamma8.07Leverage Ratio-1.0549Theta-0.0003Rho-7.81Eff Leverage0.0012Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet